Combination Hormone Therapy Followed by Radiation Therapy in Treating Patients With Prostate Cancer
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Androgens can stimulate the growth of prostate cancer cells. Hormone therapy using
triptorelin and flutamide may fight cancer by reducing the production of androgens. It is not
yet known whether giving hormone therapy for 4 months is more effective than giving therapy
for 8 months prior to radiation therapy for prostate cancer.
PURPOSE: Randomized phase III trial to study the effectiveness of combination hormone therapy
for 4 or 8 months followed by radiation therapy in treating patients with prostate cancer.